T HE PITUITARY GLAND develops from a middle structure that is contiguous with the primordium of the ventral diencephalons. Contact of the primordial stomadial ectoderm and the neuroepithelium during head folding results in the initial organ determination, forming Rathke's pouch (1, 2) . In Rathke's pouch, several transcriptional factors including LIM homeodomain transcription factor 3 (3, 4) , pituitary homeobox (5, 6) , and gene expressed in embryonic stem cells (7, 8) appear subsequently. After the proliferation of the pituitary cells, different hormone-producing cells arise from distinct spatial and temporal fashion (9) .
Differentiation of GH-producing cells is regulated by Pit-1, a pituitary-specific transcription factor (10, 11) . Pit-1 has been shown to play a pivotal role in the cell type-specific expression of the prolactin (PRL) (10) , TSH␤ (12) , and GHRH receptor gene (13) in addition to the GH gene and appears at embryonic day (e) 13.5 in mice before GH gene expression. The expression of Pit-1 is regulated by a paired-like transcription factor, Prophet of Pit-1 (Prop1) that appears at e10 before the expression of Pit-1 (14) . The expression of Prop1 is transient and disappears at e14.5. It is reported that Prop1 is required for the initial expression of Pit-1, and after the initial expression of Pit-1, Pit-1 expression is activated by factors other than Prop1.
The Ames murine dwarf (df) that shows GH, PRL, and TSH␤ deficiency has a mutated Prop1 in which Ser of codon 83 is replaced with Pro (14, 15) . The mutation is located in DNA binding domain, and the mutant Prop1 is reported not to bind PRDQ9, a consensus element of paired-like transcription factors including Prop1. As for mouse Pit-1 gene, there are two Prop1-binding sites at Ϫ7.8 and Ϫ7.9 kb from the transcription start site (14) . In human Pit-1 gene, however, there are no reports concerning Prop1-binding elements. Prop1 mutation is not rare among the patients with combined pituitary hormone deficiency (CPHD) (16, 17) . In humans the prevalence of Prop1 mutation among the patients with CPHD has been reported at 48% (16) , and many of these mutations are thought to be located within the putative DNA bindings sites (16, 18) . Because studies have been conducted showing defects in DNA binding activity of mutant Prop1 by EMSA using consensus elements of paired-like transcription factors (19 -22) , it is thought the CPHD is due to the inability of Prop1 to bind and activate the Pit-1 gene. However, this has not been directly tested because the Prop1 binding sites have not been identified in the human Pit-1 gene. Vieira et al. (19) , however, reported that Prop1 stimulated the human Pit-1 reporter plasmid containing proximal promoter site of 1.2 kb, suggesting Prop1-binding elements might be located near the transcription start site in human Pit-1 gene. To clarify the mechanism of Prop1 to activate Pit-1, it is important to identify and analyze Prop1-binding elements. In the present study, we attempted to identify Prop1-binding elements of human Pit-1 gene and analyzed the function.
Materials and Methods

Cell culture
GH3 and JEG3 cells were obtained from American Type Culture Collection (Manassas, VA), and TtT/GF, COS7, HeLa, and HuH7 cells were obtained from Riken (Saitama, Japan). These cells were cultured in DMEM with 10% (vol/vol) calf serum. Culture media contained penicillin G (100 g/ml) and kanamycin (15.5 g/ml).
Plasmids
The 1.4 kb of the 5Ј-flanking region (from Ϫ1340 to ϩ30, when the translation start site was numbered as ϩ1) of the human Pit-1 gene (National Center for Biotechnology Information accession no. NM_001122757, gene ID 5449) was PCR amplified from human genome library (CLONTECH, Mountain View, CA) using 5Ј-GGGTACCG-CTGCTTACTGACAAAGTGTTC-3Ј and 5Ј-GGGAGCTCATCAGCCG-AAGTAAAAGCTTGG-3Ј as primers. The amplified 1.4-kb Pit-1 gene was inserted into KpnI and SacI sites of multicloning site of pGL3 basic vector (Promega Japan, Tokyo, Japan), which was named Ϫ1340-Pit-1-Luc. For deletion study to identify important sites for Pit-1 gene expression, a series of PCR-amplified Pit-1 genes (from Ϫ996, Ϫ646, Ϫ492, Ϫ257, or Ϫ142 to ϩ30) were inserted into multicloning site of pGL3 basic vector, and these plasmids were named Ϫ996-, Ϫ646-, Ϫ492-, Ϫ257-, and Ϫ142-Pit-1-Luc, respectively. All the DNAs amplified by PCR were sequenced with a DNA sequencer [model ABI PRISM 377; PerkinElmer Japan (Tokyo, Japan); Applied Biosystems Japan (Tokyo, Japan)] to confirm DNA sequence. A Prop1-binding site (Ϫ63 to Ϫ53) of Ϫ257-Pit-1-Luc and Ϫ142-Pit-1-Luc was mutated with a site-directed mutagenesis kit (Stratagene, La Jolla, CA) according to the manufacturer's instructions. In the site-directed mutagenesis of both plasmids, mutant sense primer (5Ј-CGGCCCTTTGAGACAGTAGGATAATAAAACT-CTGATTTGGGG-3Ј) and mutant antisense primer (5Ј-CCCCAAATCA-GAGTTTTATTATCCTACTGTCTCAAAGGGCCG-3Ј) were used. Bold characters indicate the mutated sites. The resulting vectors were named Ϫ257M-Pit-1-Luc and Ϫ142M-Pit-1-Luc.
To evaluate the function of proximal Prop1-binding element (Ϫ63 to Ϫ53) in the presence or absence of the distal Prop1-binding elements, two sets of plasmid pairs were made. One was distal Aϩ-142Pit-1-Luc and distal Aϩ-142M-Pit-1-Luc, and the other was distal Bϩ-142Pit-1-Luc and distal Bϩ-142M-Pit-1-Luc. Distal A region (Ϫ8111 to Ϫ7954) that have two distal Prop1-binding elements was PCR amplified from human genome library (CLONTECH) using 5Ј-CGGGGTACCGAATCAATG-TAGTATAAGGCAGGT-3Ј (KpnI site is underlined) and 5Ј-TTG-GCGCGCGCTGTCTAGATAATAAAGCTCTGA-3Ј (BssHII site is underlined) as primers. The DNA region between Ϫ257 and Ϫ143 of Ϫ257-Pit-1-Luc or Ϫ257M-Pit-1-Luc was displaced with the amplified 158-bp DNA. The resulting plasmid had a 158-bp DNA region containing two distal Prop1-binding elements just upstream Ϫ142-Pit-1-Luc or Ϫ142M-Pit-1-Luc because KpnI and BssHII digestion cut out DNA region between Ϫ257 and Ϫ143. The plasmid finally had three Prop1-binding elements (two distal elements and one proximal element). To make distal Bϩ-142Pit-1-Luc and distal Bϩ-142M-Pit-1-Luc, double-strand oligonucleotides containing a Prop1-binding element (Ϫ8002 to Ϫ7988) were inserted into Ϫ142-Pit-1-Luc or Ϫ142M-Pit-1-Luc. Human Prop1 expression vector (pcDNA3.1/Prop1) was provided by Dr. T. Usui (National Hospital Organization, Kyoto Medical Center, Kyoto, Japan). Human Prop1 cDNA that had been cut out from pcDNA3.1/Prop1 was inserted into the HindIII and SmaI sites of multicloning site of pFlag-CMV-2 expression vector (Sigma-Aldrich Japan, Tokyo, Japan). 
Transient expression assays
pcDNA3.1/Prop1 (1.2 g) and a series of Pit-1 reporter plasmids (0.4 g) were transfected to GH3, TtT/GF, COS7, HeLa, JEG3, or HuH7 cells using Lipofectamine 2000 (Invitrogen Japan, Tokyo, Japan). Five nanograms of pRL-CMV containing the cDNA encoding Renilla luciferase (Promega) were also cotransfected to evaluate transfection efficiency. Cells were harvested 24 or 48 h after transfection, and luciferase activity was measured with Luminescencer-PSN (ATTO, Tokyo, Japan) using the dual-luciferase assay system (Promega). For dose-response experiments, 0.3, 0.6, or 1.2 g of pcDNA3.1/Prop1 was transfected to GH3 cells with 0.4 g of Ϫ1340-Pit-1-Luc. Luciferase activity was measured 48 h after transfection. The luciferase activity was normalized with the activity of cotransfected pRL-CMV. Values were expressed as multiples of induction relative to the activity of the pGL3 basic vector and represent mean Ϯ sd of at least four determinations, and the whole experiment was repeated three times.
Prop1 protein
The Prop1 cDNA (National Center for Biotechnology Information accession no. NM_006261) was amplified by PCR using primers (forward, 5Ј-ATGGAAGCAGAAAGGAGGCG-3Ј; reverse, 5Ј-AGAG- GATCCTCAGTTCCAGGACTTGGATG-3Ј) and pcDNA3.1/Prop1 as a template. The resulting cDNA was inserted into EcoRV and BamHI sites of the pTD1 (Shimadzu, Tokyo, Japan) to create Prop1 mRNA expression. The cDNA was transcribed using Thermo T7 transcription kit (TOYOBO, Osaka, Japan) and was purified with DyeEx 2.0 spin kit (QIAGEN). The resulting mRNA was translated using the Transdirect insect cell (Shimadzu) according to the manufacturer's instruction.
EMSA
Mobility shift assays were performed to assess the Prop1-binding activity of Pit-1 gene promoter. Four elements, the sequences of which were similar to that of paired-like transcription factors-binding motif, were located within Ϫ257 bp of Pit-1 gene. To clarify which element is important for Prop1-binding, four oligonucleotide probes (probe A, from Ϫ257 to Ϫ228; probe B, from Ϫ227 to Ϫ198; probe C, from Ϫ189 to Ϫ145; probe D, from Ϫ88 to Ϫ42) were made. To compare Prop1-binding to putative distal elements (Ϫ8068 to Ϫ8058 and Ϫ8000 to 7989) and the proximal element (Ϫ63 to Ϫ53), probe E (Ϫ8079 to Ϫ8047) and probe F (Ϫ8011 to Ϫ7979) were also made. These oligonucleotides were labeled with digoxigenin (DIG) using terminal transferase. Binding reactions contained 62 fmol of the labeled probe, varying amounts of Prop1, 1 g poly(deoxyinosine-cytosine), 0.1 g poly-l-lysine, 20 mm HEPES (pH 7.6), 1 mm EDTA, 10 mm (NH 4 ) 2 SO 4 , 1 mm dithiothreitol, 2% Tween 20, and 30 mm KCl in a total volume of 20 l. Reaction mixtures were incubated for 15 min at room temperature. For binding competition assays, 8 pmol unlabeled oligonucleotides were added to the reaction mixture. After incubation, the reaction mixtures were applied to nondenaturing polyacrylamide gel. After electrophoresis, DIGlabeled DNA fragments were transferred onto a Hybond-N-membrane (GE Healthcare, Tokyo, Japan) and detected using the DIG gel shift assay kit (Roche Diagnostics, Tokyo, Japan).
Chromatin immunoprecipitation (ChIP) assay
ChIP assay was performed using a ChIP assay kit (Upstate, Lake Placid, NY) and described elsewhere (20) . Briefly, 24 g of Flag-CMVProp1 was transfected to GH3 cells in a 10-cm dish. After 48 h, GH3 cells were fixed with 1% formaldehyde and incubated for 10 min at 37 C. Cells were washed using ice-cold PBS and pelleted by centrifugation for 4 min at 2000 rpm and resuspended in lysis buffer. The nuclei of the cells were sonicated for 30 min to reduce the DNA length to between 200 and 600 bp. Before immunoprecipitation, the chromatin was precleared with unblocked protein A Sepharose. The precleared chromatin was divided into three equal parts. One part was used immunoprecipitation with anti-Flag antibody (Sigma) and the other for negative control with or without normal mouse IgG (Santa Cruz Biotechnology, Santa Cruz, CA). Immunocomplex were precipitated with protein A Sepharose and were washed. The immunoprecipitated DNA-protein complex was eluted in 250 l of elution buffer containing 200 mm NaCl, and the Prop1-DNA cross-links were reversed by 4 h incubation at 65 C. Then proteins were digested by proteinase K at 45 C. The DNA from samples was extracted through phenol/chloroform and ethanol-precipitated with 20 g of glycogen. The immunoprecipitated DNA was analyzed by PCR. For the analysis, the following primers were used: rat Pit-1 Ϫ112-to Ϫ1-bp region primers (forward, 5Ј-GCCGCCCTGATGTATATATG-3Ј; reverse, 5Ј-CCCACAAGAGAGTAGAGAAC-3Ј) and Ϫ3659 to Ϫ3537-bp region primers (forward, 5Ј-TTTAGCTCAGTGGTAGAGCG-3Ј; reverse, 5Ј-CCTAGGTTGATTAGCCATCC-3Ј). These PCR products were verified with 2% agarose gel electrophoresis.
Statistical analysis
All data are presented as means Ϯ sd. After ANOVA analysis where appropriate, Tukey-Kramer test was used to analyze differences between groups. P Ͻ 0.05 was considered as significant.
Results
Identification of Prop1-responsive regions in the human
Pit-1 gene pcDNA3.1/Prop1 stimulated the expression of Ϫ1340-Pit-1-Luc time and dose dependently in GH3 cells (Fig. 1,  A and B) . Interestingly, the activation of Ϫ1340-Pit-1-Luc by Prop1 was observed in GH3 and TtT/GF cells but not COS7, HeLa, JEG3, and HuH7 cells (Fig. 1C) . To identify Prop1-responsive elements in human Pit-1 gene, we generated a series of reporter plasmids that have different 5Ј-end (from Ϫ1340, Ϫ996, Ϫ646, Ϫ492, or Ϫ257 to ϩ30) and examined the effect of these deletions on the reporter activity in GH3 cells. Basal luciferase activity of a series of deletion constructs was not different (Fig. 2A) . Prop1 stimulated luciferase activity of all the reporter plasmids examined (Fig. 2B) , suggesting that the Prop1-responsive elements may be present within Ϫ257-bp region from the Pit-1 translation start site.
EMSA
Within Ϫ257 bp, we found that four elements (from Ϫ255 to Ϫ246, Ϫ210 to Ϫ201, Ϫ173 to Ϫ163, and Ϫ63 to Ϫ53), which were similar to PRDQ9, consensus sequence of pairedlike transcription factors (Fig. 3A) . Because Prop1 is a member of paired-like transcription factors, we thought that the four regions (A, B, C, and D) containing the PRDQ9-like element were candidates of Prop1-binding sites and examined Prop1-binding activity of the four elements. Figure 3B shows the location of oligonucleotide probes A, B, C, and D. Probes A and B did not bind Prop1 protein. On the other hand, probes C and D showed a band of protein-DNA complex. Addition of excess of unlabeled oligonucleotide decreased Prop1-binding of probes C and D. When PRDQ9 was used as positive control, Prop1 bound the control probe (Fig.  3C ). These findings suggested that Prop1 bound to regions C and D.
Mutational analysis of Prop1-binding elements in Pit-1 gene using EMSA
To confirm that the PRDQ9-like elements located in C and D bind to Prop1, we performed EMSA using mutated probe C (Ϫ171A-ϾG and Ϫ170A-ϾG) and probe D (Ϫ61A-ϾG and Ϫ60T-ϾG) in which PRDQ9-like element was mutated (Fig.  4A) . When wild-type probe C and mutated probe C were used as a probe, there was no difference of the intensity of shifted band between the two probes. On the other hand, when mutated probe D was used, the intensity of the shifted band was dramatically reduced compared with wild-type probe D (Fig. 4B) . This finding showed that PRDQ9-like element in probe D was the actual binding site of Prop1 and that the binding of Prop1 to probe C was nonspecific binding.
Mutational analysis of Prop1-binding elements in Pit-1 gene using transient transfection assay
To confirm that mutation of PRDQ9-like element in Probe D leads to the decrease of Pit-1 promoter activity, we performed a luciferase assay in GH3 cells using Ϫ257M-Pit-1-Luc and Ϫ142M-Pit-1-Luc, in which same mutation as mutated probe D was generated. Prop1-induced activity of Ϫ257M-Pit-1-Luc and Ϫ142M-Pit-1-Luc were significantly reduced to 43 and 26% compared with Ϫ257-Pit-1-Luc and Ϫ142-Pit-1-Luc, respectively (Fig. 5A) .
Prop1 activated Ϫ1340-Pit-1-Luc expression in TtT/GF cells. To confirm the region between Ϫ63 and Ϫ53 bp is a functioning element in TtT/GF cells as well as GH3 cells, the same experiment was performed. Prop1-induced activations of Ϫ257M-Pit-1-Luc and Ϫ142M-Pit-1-Luc were significantly reduced in TtT/GF cells compared with Ϫ257-Pit-1-Luc and Ϫ142-Pit-1-Luc, respectively (Fig. 5B) . These results indicated that the region between Ϫ63 and Ϫ53 bp (proximal Prop1-binding element) was an essential element for Prop1-induced activation of human Pit-1 reporter gene.
Comparison of Prop1-binding to distal and proximal Prop1-binding elements
There are two Prop1-binding sites at Ϫ7.8 and Ϫ7.9 kb in mouse Pit-1 gene, and the regions are thought to be involved in early activation of mouse Pit-1 gene. In human Pit-1 gene, two putative distal Prop1-binding elements are also con-FIG. 5. Mutation of the proximal Prop1-binding element resulted in diminished luciferase activity of Pit-1 reporter plasmid. A, Ϫ257-Pit-1-Luc contains four PRDQ9-like elements (Ϫ255 to Ϫ246, Ϫ210 to Ϫ201, Ϫ173 to Ϫ163, and Ϫ63 to Ϫ53). Ϫ142-Pit-1-Luc contains one PRDQ9-like element (Ϫ63 to Ϫ53). Prop1-induced activations of Ϫ257M-Pit-1-Luc and Ϫ142M-Pit-1-Luc, in which the same mutation (Mut) as mutated probe D was generated, were significantly reduced to 43 and 26% compared with Ϫ257-Pit-1-Luc and Ϫ142-Pit-1-Luc, respectively, in GH3 cells. B, Prop1-induced activations of Ϫ257M-Pit-1-Luc and Ϫ142M-Pit-1-Luc were also significantly reduced in TtT/GF cells. *, P Ͻ 0.05. served, suggesting that the distal Prop1-binding elements may function in human Pit-1 gene expression. We examined Prop1 binding to the distal and proximal Prop1-binding elements with EMSA. Probe D containing the proximal Prop1-binding element and probe F containing a distal Prop1-binding element (Ϫ8000 to 7989) showed definite shifted bands. The band intensity of these probes was stronger than that of probe E that have another putative Prop1-binding element (Ϫ8068 to Ϫ8058). PRDQ9 was used as positive control (Fig. 6) .
Mutational analysis of the proximal Prop1-binding element in Pit-1 reporter gene that has distal Prop1binding elements using transient transfection assay
To clarify the role of the proximal Prop1-binding element (Ϫ63 and Ϫ53) in the presence of distal Prop1-binding elements, we compared luciferase activities of distal Aϩ-142Pit-1-Luc and distal Bϩ-142Pit-1-Luc with those of distal Aϩ-142M-Pit-1-Luc and distal Bϩ-142MPit-1-Luc, respectively. Mutation of the proximal Prop1-binding element resulted in decreased luciferase activity in both experiments, although the addition of distal Prop1 binding-sites increased luciferase activity. Prop1-induced activations of Ϫ142M-Pit-1-Luc, distal Aϩ-142M-Pit-1-Luc, and distal Bϩ-142MPit-1-Luc were significantly reduced to 28, 55, and 35% compared with Ϫ142-Pit-1-Luc, distal Aϩ-142Pit-1-Luc, and distal Bϩ-142Pit-1-Luc, respectively (Fig. 7A) . In addition, this experiment was performed in TtT/GF cells. The involvement of the region between Ϫ63 and Ϫ53 bp in Pit-1 reporter gene expression was also confirmed in TtT/GF cells (Fig. 7B) , although the activities induced by Prop1 was not so high as in GH3 cells.
ChIP assay
To confirm the binding of Prop1 to the region including probe D in cultured cells, we performed ChIP assay. PCR product corresponding Ϫ112 to Ϫ1-bp region was detected . Distal Aϩ-142Pit-1-Luc and distal Bϩ-142Pit-1-Luc, both of which contains distal Prop1-binding element in addition to the proximal Prop1-binding element, showed higher luciferase activity than 142Pit-1-Luc that have no distal Prop1-binding element. On the other hand, two nucleotide mutations (from Ϫ61 to Ϫ60) of the proximal Prop1-binding element (from Ϫ63 to Ϫ53) resulted in decreased luciferase activity in response to Prop1. The results are shown as relative fold increase Ϯ SD of luciferase activities compared with control transfected with pcDNA3.1. Prop1-induced activations of distal Aϩ-142M-Pit-1-Luc and distal Bϩ-142M-Pit-1-Luc were significantly reduced to 55 and 35% compared with distal Aϩ-142Pit-1-Luc and distal Bϩ-142Pit-1-Luc, respectively. B, In TtT/GF cells, mutation of the proximal Prop1-binding element led to reduced activity in response to Prop1. Distal Aϩ-142M-Pit-1-Luc and distal Bϩ-142M-Pit-1-Luc were significantly reduced compared with distal Aϩ-142Pit-1-Luc and distal Bϩ-142Pit-1-Luc, respectively. *, P Ͻ 0.05.
in the sample immunoprecipitated with Flag antibody in Flag-CMV-Prop1-transfected GH3 cells but not in the sample immunoprecipitated with normal mouse IgG. The Ϫ3659 to Ϫ3537-bp region, in which PRDQ9-like elements are not present, was not amplified from either sample immunoprecipitated with Flag antibody or with normal mouse IgG. This finding suggested that Prop1 specifically bound to the region Ϫ112 to Ϫ1 bp (Fig. 8) .
Comparison of wild and mutant Prop1-binding to the proximal Prop1-binding element
A mutant Prop1, W194X Prop1 that has a mutation in C-terminal region not in DNA binding domain is reported to show less binding activity to PRDQ9. Because wild Prop1 showed apparently weaker binding to probe D than PRDQ9 as shown in Fig. 3 , W194X Prop1 may show much less binding to probe D. However, wild and W194X Prop1 did not show marked difference in the intensity of the shifted band when probe D or PRDQ9 was used, although the binding to PRDQ9 appeared stronger than that to probe D when either Prop1 was used (Fig. 9) .
Discussion
We revealed a Prop1-binding site in human Pit-1 gene. The Prop1-binding site is located in the first exon that is not translated. The mutation of the element decreased both the binding of Prop1 and the activation of reporter plasmid, indicating that the element is a functioning element leading to Pit-1 expression. Furthermore, ChIP assay suggested Prop1 could bind to the element in vivo. Interestingly, Prop1 stimulated the Pit-1 reporter gene expression in GH3 and TtT/GF cells but not in other cell lines. GH3 cells are rat pituitary cells that produce PRL and GH, and TtT/GF cells have a character of pituitary folliculostellate cells (21) . Although TtT/GF cells do not produce any pituitary hormones, the cells were reported to express Pit-1 mRNA (22) . TtT/GF cells may have similar machinery for producing GH, PRL, and TSH␤ to GH3 cells. Prop1 alone did not stimulate Pit-1 reporter activity in nonpituitary cells. The fact that only in pituitary-derived cells Prop1 can activate a promoter indicates that other pituitary-specific factors are involved in Prop1 mediated Pit-1 gene transcription, but these factors remain to be identified.
Mouse Pit-1 gene has proximal and distal enhancer sites. Sornson et al. (14) already reported that the Ϫ10 to Ϫ5 kb region of the 5Ј-flanking region of mouse Pit-1 gene is important for its initial expression, whereas the region until Ϫ5 kb is not essential to the initial expression of Pit-1 using Lac-Z transgenic mice that were driven by 5Ј-flanking region of Pit-1 gene. They also showed that there were two Prop1-binding sites at Ϫ7.8 and Ϫ7.9 kb within the region and that Prop1 stimulated the expression of reporter plasmid that had three Ϫ7.8 Prop1-binding sites in transient expression assay. Prop1 expression occurs before Pit-1 expression. Ames mice that have mutant Prop1 show similar phenotype to Snell mice that have Pit-1 mutation and Pit-1 lineage cells (GH, PRL, and TSH cells) are not observed in Ames mice (14) . These findings indicate that Prop1 is the activating factor for Pit-1 gene expression. Thus, Prop1-binding site at Ϫ7.8 kb is thought as an essential site for the initial activation of Pit-1 gene.
However, it is of note that mouse Pit-1 promoter region until Ϫ5 kb in Lac-Z transgenic mice did not contain the element corresponding to Ϫ63 to Ϫ53 bp shown in the present study (23, 24) . The result in Lac-Z transgenic mice by Sornson (14) does not exclude the possibility that the Prop1-binding element from Ϫ63 to Ϫ53 bp plays a role in Pit-1 expression. Considering the result of present study, the Prop1-binding site is likely to be an element regulating Pit-1 expression. Indeed, the element is conserved in several animals including humans, monkeys, rats, mice, and pigs, suggesting the importance of the element (Fig. 10) . The distal Prop1-binding region is also conserved in human Pit-1 gene and may play a role in Pit-1 gene expression in humans. To clarify the significance of the distal and proximal Prop1 binding elements in human Pit-1 gene, we made distal Aϩ-142Pit-1-Luc and distal Bϩ-142Pit-1-Luc Pit-1 reporter plasmids containing the distal and proximal prop1-binding elements. Addition of distal Prop1-binding elements increased luciferase activity, suggesting that the distal elements have an enhancer activity. However, in the presence or absence of the distal Prop1 binding element, mutation of proximal Prop1-binding element resulted in decrease of luciferase activity, indicating the significance of the proximal Prop1-binding element in Pit-1expression.
Prop1 expression is occurred at e10 in mice and disappeared at e14.5. Prop1 is not present in adult pituitary, although Prop1 mRNA is reported in human normal pituitary (25) and pituitary tumors (25, 26) . Because it is difficult to assess whether endogenous Prop1 binds to Pit-1 genome DNA, we used transfection of Prop1 to GH3 cells and ChIP assay to confirm in vivo binding. Consistent with EMSA, the specific region containing the proximal Prop1-binding element was amplified by PCR, suggesting that the Prop1-binding element from Ϫ63 to Ϫ53 bp indeed binds to Prop1 in vivo.
The prevalence of Prop1 mutation among the patients with CPHD has been reported 48% (16) . However, the molecular mechanism how mutant Prop1 causes the disease has remained unclear, although the mechanism was examined in several cases. To date almost all of Prop1 mutations were identified in DNA binding domain. The loss of DNA binding has been examined in EMSA using PRDQ9 because the Porp1-binding element in human Pit-1 gene was not identified. It was recently reported that some patients with CPHD have mutations in the putative transactivation domain but not DNA-binding domain of Prop1 (27, 28) . Among the mutations, a mutation W194X Prop1 showed less DNA binding to PRDQ9 than the wild Prop1 (27) , suggesting the possibility that a domain other than DNA binding domain affects the binding affinity. Because the present study showed that the intensity of shifted probe D was weaker than that of PRDQ9 when wild Prop1 was used (Fig. 3C) , W194X Prop1 might show much lower binding to the region Ϫ63 to Ϫ53, which is included in probe D. This could lead to low expression of Pit-1. However, we did not find a difference in the binding of wild and W194X Prop1 for probe D as well as PRDQ9 (Fig.  7) . Thus, we think the defect of interaction with cofactors but not the defect of DNA binding would be responsible for CPHD induced by W194X Prop1.
In summary, we found a Prop1-binding element in the first exon of the human Pit-1 gene. The mutation of the element resulted in diminished binding to Prop1 and decreased expression of the Pit-1 reporter plasmid, suggesting that the Prop1-binding element plays a role in Pit-1 expression. Furthermore, ChIP assay showed that the element could bind Prop1 in vivo cultured cells.
